CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires VivoPath LLC
Snapshot
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired VivoPath LLC for $2.3 million (including $1.6 million in contingent consideration) in June 2014. The transaction was structured as all cash. VivoPath LLC is a United States-based Discovery and Safety Assessment (DSA) — In Vivo Discovery business.
- Acquirer
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Target
- VivoPath LLC
- Value
- $2.3 million (including $1.6 million in contingent consideration)
- Date
- June 2014
- Type
- asset purchase
- Status
- ready
The deal at a glance
About this deal
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired VivoPath LLC for $2.3 million (including $1.6 million in contingent consideration), a transaction completed in June 2014, structured as all cash. The deal was a asset purchase.
VivoPath LLC operates in Discovery and Safety Assessment (DSA) — In Vivo Discovery, is based in United States. VivoPath LLC was a discovery service company specializing in the rapid, in vivo compound evaluation of molecules in the therapeutic areas of metabolism, inflammation and oncology.
In June 2014, the Company acquired substantially all of the assets of VivoPath LLC (VivoPath), a discovery service company specializing in the rapid, in vivo compound evaluation of molecules in the therapeutic areas of metabolism, inflammation and oncology.
In Vivo Discovery business, DSA segment
No advisory firms have been disclosed for this transaction.